Descon Oxychem takes a hit as imports flood the market
Some exporting customers are allowed to purchase foreign competitors’ products, causing Descon to lose market share
As Panadol prices stabilise, Haleon’s revenue growth slows
The boost from deregulated drug prices is stalling, causing Haleon to look at new product launches in nutraceuticals and export markets for growth
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in salesÂ
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
Saudi investors exit Pakistan’s largest pharmacy chain. What happened and why?
From its origins as part of the Servis Group to multiple changes in ownership since its inception in 2005, Servaid has undergone an eventful two decades in existence
Macter gaining market share, and diversifying into cosmetics
The biopharmaceutical manufacturer saw revenue growth faster than industry average, and also plans to launch a GLP 1 product
Afghan trade halt hits Pakistan’s $200 million pharma exports, medicine containers struck at Torkham, Chaman borders
PPMA warns over 50 pharma firms face losses as temperature-sensitive medicines risk expiry; industry urges govt to allow exports on humanitarian grounds
Pharmaceuticals: how the locals are beating the multinationals
In a heavily regulated market, the local players have learned to live with the price rules the way they are, while the foreign players still seem to have hope that things will change
Pharma sector thrives with 21.79% growth amid economic stagnation
Deregulation policy drives record sales, but patients face rising costs
Pharma sector earnings rise 3.1x to Rs24.8bn in 2024, driven by 15% rise in net sales
Net sales reach Rs318bn, gross margins improve to 36%, while finance costs rise to Rs8bn in 2024; deregulation of drug prices boosts profitability.
BF Biosciences expands production, launches diabetes treatment, secures listing approval
Company receives approval for brownfield expansion and launches Sematide, a new diabetes treatment, while listing application is greenlit by SECP and PSX
Senate panel alarmed as medicine prices jump 32% after price controls lifted
Health ministry reports some essential drugs have doubled in cost, prompting inquiry into deregulation impact; Pharmaceutical Manufacturers Association disputes the official figures
DRAP’s survey on drug price hikes irks pharmaceutical manufacturers
Third-party survey initiated in response to public outcry over rising medicine prices after deregulation of non-essential drugs; PPMA voices concerns over lack of industry stakeholder involvement
OBS Pakistan amalgamates AGP with AitkenStuart
It is pertinent to mention that rumours had been circulating that OBS Pakistan was going through major restructuring and this acquisition by Searle comes as a surprise for the market.
Pakistan’s pharmaceutical exports hit 34% growth in FY25, marking a two-decade high
Exports of locally produced medicines reach $457 million, with deregulation policy boosting growth
Pakistan’s medicinal imports rise by 9.74pc
ISLAMABAD: Pakistan imported medicinal product worth $656.092 million during the first seven months of current fiscal year, showing growth of 9.74 per...